Your browser doesn't support javascript.
loading
Drug-sensitive FGFR3 mutations in lung adenocarcinoma.
Chandrani, P; Prabhash, K; Prasad, R; Sethunath, V; Ranjan, M; Iyer, P; Aich, J; Dhamne, H; Iyer, D N; Upadhyay, P; Mohanty, B; Chandna, P; Kumar, R; Joshi, A; Noronha, V; Patil, V; Ramaswamy, A; Karpe, A; Thorat, R; Chaudhari, P; Ingle, A; Choughule, A; Dutt, A.
Afiliación
  • Chandrani P; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Prabhash K; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India.
  • Prasad R; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India.
  • Sethunath V; Department of Medical Oncology, Tata Memorial Hospital, Navi Mumbai, India.
  • Ranjan M; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Iyer P; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Aich J; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Dhamne H; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Iyer DN; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India.
  • Upadhyay P; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Mohanty B; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Chandna P; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Kumar R; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Joshi A; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India.
  • Noronha V; Small Animal Imaging Facility, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Patil V; AceProbe Technologies Pvt. Ltd, New Delhi, India.
  • Ramaswamy A; Department of Pathology, Tata Memorial Hospital, Navi Mumbai, India.
  • Karpe A; Department of Medical Oncology, Tata Memorial Hospital, Navi Mumbai, India.
  • Thorat R; Department of Medical Oncology, Tata Memorial Hospital, Navi Mumbai, India.
  • Chaudhari P; Department of Medical Oncology, Tata Memorial Hospital, Navi Mumbai, India.
  • Ingle A; Department of Medical Oncology, Tata Memorial Hospital, Navi Mumbai, India.
  • Choughule A; Department of Medical Oncology, Tata Memorial Hospital, Navi Mumbai, India.
  • Dutt A; Department of Pathology, Tata Memorial Hospital, Navi Mumbai, India.
Ann Oncol ; 28(3): 597-603, 2017 03 01.
Article en En | MEDLINE | ID: mdl-27998968
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Resistencia a Antineoplásicos / Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Resistencia a Antineoplásicos / Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article